Financials
- Market Capitalization 255.2 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.8
売上高対価格比率
0.04
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3429 | MGNX MacroGenics, Inc. - Common Stock | 4.25 USD | -0.93% | -7.41% | +2.41% | +183.33% | 270.14 M USD | ||
| 3448 | TRDA Entrada Therapeutics, Inc. - Common Stock | 6.83 USD | +0.44% | -5.79% | +4.59% | -2.01% | 265.14 M USD | ||
| 3479 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 8.48 USD | -1.62% | -14.69% | -1.62% | -7.42% | 249.16 M USD | ||
| 3495 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 9.89 USD | +5.78% | +0.41% | +8.21% | +137.74% | 244.45 M USD |